Symbol="ENTX"
AssetType="Common Stock"
Name="Entera Bio Ltd"
Description="Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical needs. The company is headquartered in Jerusalem, Israel."
CIK="1638097"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="23336500"
EBITDA="-11789000"
PERatio="None"
PEGRatio="None"
BookValue="0.35"
DividendPerShare="0"
DividendYield="0"
EPS="-0.39"
RevenuePerShareTTM="0.002"
ProfitMargin="0"
OperatingMarginTTM="-179.56"
ReturnOnAssetsTTM="-0.437"
ReturnOnEquityTTM="-0.77"
RevenueTTM="66000"
GrossProfitTTM="33000"
DilutedEPSTTM="-0.39"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.915"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="63.37"
PriceToBookRatio="1.262"
EVToRevenue="13.56"
EVToEBITDA="-0.277"
Beta="1.846"
num_52WeekHigh="1.97"
num_52WeekLow="0.472"
num_50DayMovingAverage="0.838"
num_200DayMovingAverage="0.851"
SharesOutstanding="28814000"
DividendDate="None"
ExDividendDate="None"
symbol="ENTX"
open="0.82"
high="0.82"
low="0.80"
price="0.81"
volume="44679.00"
latest_trading_day="2023-07-28"
previous_close="0.80"
change="0.01"
change_percent="1.7718%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="54"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="46"
Volume_recent_avg="70393"
Change_recent_avg="-0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.99"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0019.jpeg"
image_negative_thumbnail_id_2="1096"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0129.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="558"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_positive_thumbnail_id_1="973"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_positive_thumbnail_id_2="1003"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
